Trademark: 97583724
Word
ELKAVY
Status
Pending
Status Code
686
Status Date
Tuesday, April 9, 2024
Serial Number
97583724
Mark Type
4000
Filing Date
Thursday, September 8, 2022
Published for Opposition
Tuesday, April 9, 2024

Trademark Owner History
Ipsen Pharma S.A.S. - Owner At Publication

Classifications
5 Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue disease, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospam, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations containing notably botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified components of the toxin haemagglutin complex for skin care and the treatment of neurological disorders

Trademark Events
Apr 9, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 9, 2024
Published For Opposition
Mar 20, 2024
Notification Of Notice Of Publication E-Mailed
Mar 4, 2024
Approved For Pub - Principal Register
Feb 28, 2024
Assigned To Examiner
Feb 9, 2024
Teas/Email Correspondence Entered
Feb 9, 2024
Correspondence Received In Law Office
Feb 9, 2024
Assigned To Lie
Sep 19, 2023
Teas Response To Office Action Received
Jun 26, 2023
Notification Of Non-Final Action E-Mailed
Jun 26, 2023
Non-Final Action E-Mailed
Jun 26, 2023
Non-Final Action Written
Jun 22, 2023
Assigned To Examiner
Sep 14, 2022
New Application Office Supplied Data Entered
Sep 12, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24